203 related articles for article (PubMed ID: 37872166)
1. Immune checkpoint inhibitor-induced colitis is mediated by polyfunctional lymphocytes and is dependent on an IL23/IFNγ axis.
Lo JW; Cozzetto D; Alexander JL; Danckert NP; Madgwick M; Knox N; Sieh JYX; Olbei M; Liu Z; Ibraheim H; Blanco JM; Kudo H; Seoane RC; Possamai LA; Goldin R; Marchesi J; Korcsmaros T; Lord GM; Powell N
Nat Commun; 2023 Oct; 14(1):6719. PubMed ID: 37872166
[TBL] [Abstract][Full Text] [Related]
2. Tracking in situ checkpoint inhibitor-bound target T cells in patients with checkpoint-induced colitis.
Gupta T; Antanaviciute A; Hyun-Jung Lee C; Ottakandathil Babu R; Aulicino A; Christoforidou Z; Siejka-Zielinska P; O'Brien-Ball C; Chen H; Fawkner-Corbett D; Geros AS; Bridges E; McGregor C; Cianci N; Fryer E; Alham NK; Jagielowicz M; Santos AM; Fellermeyer M; Davis SJ; Parikh K; Cheung V; Al-Hillawi L; Sasson S; Slevin S; Brain O; ; Fernandes RA; Koohy H; Simmons A
Cancer Cell; 2024 May; 42(5):797-814.e15. PubMed ID: 38744246
[TBL] [Abstract][Full Text] [Related]
3. Interferon-Gamma-Producing CD8
Sasson SC; Slevin SM; Cheung VTF; Nassiri I; Olsson-Brown A; Fryer E; Ferreira RC; Trzupek D; Gupta T; Al-Hillawi L; Issaias ML; Easton A; Campo L; FitzPatrick MEB; Adams J; Chitnis M; Protheroe A; Tuthill M; Coupe N; Simmons A; Payne M; Middleton MR; Travis SPL; ; Fairfax BP; Klenerman P; Brain O
Gastroenterology; 2021 Oct; 161(4):1229-1244.e9. PubMed ID: 34147519
[TBL] [Abstract][Full Text] [Related]
4. Divergent Roles of Interferon-γ and Innate Lymphoid Cells in Innate and Adaptive Immune Cell-Mediated Intestinal Inflammation.
Brasseit J; Kwong Chung CKC; Noti M; Zysset D; Hoheisel-Dickgreber N; Genitsch V; Corazza N; Mueller C
Front Immunol; 2018; 9():23. PubMed ID: 29416538
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulation of experimental colitis: the role of NK1.1 liver lymphocytes and surrogate antigens--bystander effect.
Shlomai A; Trop S; Gotsman I; Jurim O; Diment J; Alper R; Rabbani E; Engelhardt D; Ilan Y
J Pathol; 2001 Nov; 195(4):498-507. PubMed ID: 11745683
[TBL] [Abstract][Full Text] [Related]
6. Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy.
Luoma AM; Suo S; Williams HL; Sharova T; Sullivan K; Manos M; Bowling P; Hodi FS; Rahma O; Sullivan RJ; Boland GM; Nowak JA; Dougan SK; Dougan M; Yuan GC; Wucherpfennig KW
Cell; 2020 Aug; 182(3):655-671.e22. PubMed ID: 32603654
[TBL] [Abstract][Full Text] [Related]
7. Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers.
Gray MJ; Gong J; Hatch MM; Nguyen V; Hughes CC; Hutchins JT; Freimark BD
Breast Cancer Res; 2016 May; 18(1):50. PubMed ID: 27169467
[TBL] [Abstract][Full Text] [Related]
8. Immune-related adverse events in checkpoint blockade: Observations from human tissue and therapeutic considerations.
Williams KC; Gault A; Anderson AE; Stewart CJ; Lamb CA; Speight RA; Rajan N; Plummer R; Pratt AG
Front Immunol; 2023; 14():1122430. PubMed ID: 36776862
[TBL] [Abstract][Full Text] [Related]
9. CD1d-Dependent iNKT Cells Control DSS-Induced Colitis in a Mouse Model of IFNγ-Mediated Hyperinflammation by Increasing IL22-Secreting ILC3 Cells.
Park HJ; Lee SW; Van Kaer L; Hong S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513946
[TBL] [Abstract][Full Text] [Related]
10. Checkpoint Inhibitor Colitis Shows Drug-Specific Differences in Immune Cell Reaction That Overlap With Inflammatory Bowel Disease and Predict Response to Colitis Therapy.
Lo YC; Price C; Blenman K; Patil P; Zhang X; Robert ME
Am J Clin Pathol; 2021 Jul; 156(2):214-228. PubMed ID: 33555016
[TBL] [Abstract][Full Text] [Related]
11. Interferon-γ-dependent immune responses contribute to the pathogenesis of sclerosing cholangitis in mice.
Ravichandran G; Neumann K; Berkhout LK; Weidemann S; Langeneckert AE; Schwinge D; Poch T; Huber S; Schiller B; Hess LU; Ziegler AE; Oldhafer KJ; Barikbin R; Schramm C; Altfeld M; Tiegs G
J Hepatol; 2019 Oct; 71(4):773-782. PubMed ID: 31173810
[TBL] [Abstract][Full Text] [Related]
12. Diet Modifies Colonic Microbiota and CD4
Chen L; He Z; Iuga AC; Martins Filho SN; Faith JJ; Clemente JC; Deshpande M; Jayaprakash A; Colombel JF; Lafaille JJ; Sachidanandam R; Furtado GC; Lira SA
Gastroenterology; 2018 Oct; 155(4):1177-1191.e16. PubMed ID: 29909020
[TBL] [Abstract][Full Text] [Related]
13. Early expression of interferon gamma following oral antigen administration is associated with peripheral tolerance induction.
Kolker O; Klein A; Alper R; Menachem Y; Shibolet O; Rabbani E; Engelhardt D; Ilan Y
Microbes Infect; 2003 Jul; 5(9):807-13. PubMed ID: 12850207
[TBL] [Abstract][Full Text] [Related]
14. Our current understanding of checkpoint inhibitor therapy in cancer immunotherapy.
Goleva E; Lyubchenko T; Kraehenbuehl L; Lacouture ME; Leung DYM; Kern JA
Ann Allergy Asthma Immunol; 2021 Jun; 126(6):630-638. PubMed ID: 33716146
[TBL] [Abstract][Full Text] [Related]
15. The role of intrahepatic CD8+ T cell trapping and NK1.1+ cells in liver-mediated immune regulation.
Shibolet O; Alper R; Zolotarov L; Trop S; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
Clin Immunol; 2004 Apr; 111(1):82-92. PubMed ID: 15093555
[TBL] [Abstract][Full Text] [Related]
16. Targeting PARP-1 with metronomic therapy modulates MDSC suppressive function and enhances anti-PD-1 immunotherapy in colon cancer.
Ghonim MA; Ibba SV; Tarhuni AF; Errami Y; Luu HH; Dean MJ; El-Bahrawy AH; Wyczechowska D; Benslimane IA; Del Valle L; Al-Khami AA; Ochoa AC; Boulares AH
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33495297
[TBL] [Abstract][Full Text] [Related]
17. Ex vivo modelling of PD-1/PD-L1 immune checkpoint blockade under acute, chronic, and exhaustion-like conditions of T-cell stimulation.
Roberts A; Bentley L; Tang T; Stewart F; Pallini C; Juvvanapudi J; Wallace GR; Cooper AJ; Scott A; Thickett D; Lugg ST; Bancroft H; Hemming B; Ferris C; Langman G; Robinson A; Chapman J; Naidu B; Pinkney T; Taylor GS; Brock K; Stamataki Z; Brady CA; Curnow SJ; Gordon J; Qureshi O; Barnes NM
Sci Rep; 2021 Feb; 11(1):4030. PubMed ID: 33597595
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 6 Increases Production of Cytokines by Colonic Innate Lymphoid Cells in Mice and Patients With Chronic Intestinal Inflammation.
Powell N; Lo JW; Biancheri P; Vossenkämper A; Pantazi E; Walker AW; Stolarczyk E; Ammoscato F; Goldberg R; Scott P; Canavan JB; Perucha E; Garrido-Mesa N; Irving PM; Sanderson JD; Hayee B; Howard JK; Parkhill J; MacDonald TT; Lord GM
Gastroenterology; 2015 Aug; 149(2):456-67.e15. PubMed ID: 25917784
[TBL] [Abstract][Full Text] [Related]
19. Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer.
Liu C; Liu R; Wang B; Lian J; Yao Y; Sun H; Zhang C; Fang L; Guan X; Shi J; Han S; Zhan F; Luo S; Yao Y; Zheng T; Zhang Y
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462141
[TBL] [Abstract][Full Text] [Related]
20. Immune cells and their inflammatory mediators modify β cells and cause checkpoint inhibitor-induced diabetes.
Perdigoto AL; Deng S; Du KC; Kuchroo M; Burkhardt DB; Tong A; Israel G; Robert ME; Weisberg SP; Kirkiles-Smith N; Stamatouli AM; Kluger HM; Quandt Z; Young A; Yang ML; Mamula MJ; Pober JS; Anderson MS; Krishnaswamy S; Herold KC
JCI Insight; 2022 Sep; 7(17):. PubMed ID: 35925682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
